#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Demyelination Acquired ATTR amyloidosis Cold type haemolytic anaemia Metastatic malignant melanoma Von Hippel-Lindau disease Scleroderma associated digital ulcer Parkinson's disease Methylmalonic acidaemia Fatty acid oxidation disorder Gastroenteropancreatic neuroendocrine tumour disease Hyperchylomicronaemia Chronic hepatitis B Pituitary-dependent Cushing's syndrome Pulmonary fibrosis Superficial vein thrombosis More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) Methylmalonic acidaemia – Trials in Disease Stevens-Johnson syndrome – Basic Information Alport’s syndrome – Trials in Disease Fabry’s disease – Life with Disease Brain stem glioma – Diagnostics Ornithine transcarbamoylase deficiency – Life with Disease Rosai-Dorfman syndrome Pituitary-dependent Cushing’s syndrome Mucopolysaccharidosis II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorpromazine Hydrochloride Omp12 Sertindole TX000045 Depemokimab Lisaftoclax Mk-0482 Carboplatin Exidavnemab Atropine Sulfate Antithymocyte Immunoglobulin Flutemetamol (18F) Cyclophosphamide Regadenoson Berubicin Hydrochloride 534 Palmidrol Fludeoxyglucose (18F) Dactinomycin Poractant Alfa More therapies…

    Learn about Your Condition

    Apathy Rubella Complex regional pain syndrome Neck pain Addison's disease Splenic marginal zone lymphoma Pleural mesothelioma malignant Non-obstructive cardiomyopathy Hyperoxaluria Aphthous ulcer Mitral valve prolapse HER2 positive breast cancer Follicular lymphoma stage III Nodular melanoma Patent ductus arteriosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study on Ulcerative Colitis: Evaluating Early Treatment with Adalimumab for Patients with Severe Symptoms

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    Norway

  • Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Infliximab
    Finland

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Lutikizumab
    • Adalimumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study on the Effects of Adalimumab, Vedolizumab, and Tofacitinib on Heart Health in Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Adalimumab
    • Golimumab
    France

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain
Previous Page
1 … 7 8 9 10 11 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!